Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000886163-21-000058
Filing Date
2021-04-23
Accepted
2021-04-23 16:09:26
Documents
11
Period of Report
2021-06-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A ligand-2021annualmeetingpr.htm DEF 14A 844447
2 image1.jpg GRAPHIC 14261
3 image_01.jpg GRAPHIC 12141
4 image_101.jpg GRAPHIC 510098
5 image_111.jpg GRAPHIC 475488
6 image_21.jpg GRAPHIC 268584
7 image_31.jpg GRAPHIC 230720
8 image_41.jpg GRAPHIC 72304
9 image_91.jpg GRAPHIC 537811
10 proxycard1of21a.jpg GRAPHIC 168272
11 proxycard2of21a.jpg GRAPHIC 172237
  Complete submission text file 0000886163-21-000058.txt   4214835
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33093 | Film No.: 21849795
SIC: 2834 Pharmaceutical Preparations